About Julie Saiki
Form D filings for Azora Therapeutics from 2021 to 2023 list Julie Saiki as secretary and director.
Julie Saiki first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Julie Saiki in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Julie Saiki works with at each company, as listed on that company's latest Form D.
Azora Therapeutics, Inc. · Form D, Aug 9, 2023
DB
Dennis Brown
Director
MD
Matthew Davidson
Executive officer and director